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Abstract Visual arrestin binds to the phosphorylated carboxy-
terminal region of rhodopsin to block interactions with trans-
ducin and terminate signaling in the rod photoreceptor cells. A
synthetic seven-phospho-peptide from the C-terminal region of
rhodopsin, Rh(330^348), has been shown to bind arrestin and
mimic inhibition of signal transduction. In this study, we exam-
ine conformational changes in this synthetic peptide upon bind-
ing to arrestin by high-resolution proton nuclear magnetic res-
onance (NMR). We show that the peptide is completely
disordered in solution, but becomes structured upon binding to
arrestin. A control, unphosphorylated peptide that fails to bind
to arrestin remains highly disordered. Speci¢c NMR distance
constraints are used to model the arrestin-bound conformation.
The models suggest that the phosphorylated carboxy-terminal
region of rhodopsin, Rh(330^348), undergoes signi¢cant confor-
mational changes and becomes structured upon binding to ar-
restin.
- 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Deactivation of G protein-coupled receptors occurs through
phosphorylation of multiple serine and threonine sites at the
carboxy-terminus by speci¢c receptor kinases and subsequent
binding of a protein arrestin, which physically prevents inter-
actions between the activated receptor and the G protein [1].
This mechanism has been especially well studied for the inter-
actions between light receptor rhodopsin and visual arrestin
[2^4]. Numerous studies have focused on the mechanism of
arrestin binding, and conformational changes in the arrestin
molecule that are associated with arrestin activation [5,6].
Whether complementary conformational changes occur in
the phosphorylated C-terminal region of rhodopsin during
rhodopsin^arrestin interactions is unclear. We studied a syn-
thetic polypeptide derived from the C-terminal amino acid
sequence of bovine rhodopsin, region Rh(330^348), and
chemically phosphorylated at all seven positions, seven-phos-
pho-peptide, 7PP [7], by high-resolution proton nuclear mag-
netic resonance spectroscopy (NMR). We con¢rm the ex-
tended conformation of this polypeptide in solution and
report the arrestin-bound conformation determined by trans-
ferred nuclear Overhauser e¡ect (TrNOE) spectroscopy.
2. Materials and methods
2.1. Arrestin and phosphorylated peptide
Arrestin was prepared by the method of Buczylko and Palczewski
with modi¢cations as described earlier [8]. Peptide Rh(330^348) from
the sequence of bovine rhodopsin was synthesized by standard Fmoc
chemistry on an Applied Biosystem model 431A peptide synthesizer.
Multiply phosphorylated peptide 7-phospho-Rh(330^348), 7PP, was
synthesized on phenylacetamidomethyl polystyrene resin using Boc-
O-(diphenylphosphono)-serine and -threonine as described [7]. The
peptides were homogeneous by high performance liquid chromatog-
raphy and showed the expected mass when examined by matrix-as-
sisted laser desorption/ionization time of £ight mass spectrometry [7].
2.2. NMR and structure calculations
NMR samples contained 0.16 mM of puri¢ed arrestin, 1.77 mM of
7PP, 7-phospho-Rh(330^348) or unphosphorylated Rh(330^348) in
sodium phosphate bu¡er, 0.1 M, pH 6.5 and 10% D2O in a total
volume of 0.6 ml. Two-dimensional high-resolution proton TrNOESY
spectra were acquired at 4‡C on the Varian Unity-600 spectropho-
tometer essentially as described earlier [9]. Data were processed o¡-
line using VNMR 5.2. Total correlation spectroscopy [10] (2D
TOCSY, MLEV-17 mixing sequence of 120 ms, £anked by two 2 ms
trim pulses, 0.5 s preacquisition delay and 1.0 s presaturation), and
2D NOESY [11] (tmix = 250 ms, 2U280U2049 data matrix with 16
scans per t1, using WATERGATE water suppression protocol) were
used for sequence-speci¢c and stereo-speci¢c assignments. Preliminary
TrNOESY experiments of 7PP and arrestin utilized a range of tmix
from 80 ms to 250 ms. NOE built-up curves were mostly linear up to
tmix = 250 ms. In order to minimize indirect magnetization transfer
e¡ects, a linear phase of NOE built-up at lower tmix is preferable.
However, the intensity of the NOE spectra at lower tmix was very
weak. Although some spin di¡usion was noticed at tmix = 250 ms,
most NOE peak intensities did not saturate and remained roughly
proportional to the interproton distances. For example, NH-LH and
NH-QH peaks of K339 are stronger than NH-NH by a factor of eight
and four respectively. Thus, semi-quantitative analysis is warranted.
During standard procedures NOEs are classi¢ed into weak, medium
and strong based on the peak volume and translated to corresponding
interproton distances of 1.9^5.0 AK , 1.9^3.5 AK , and 1.9^2.7 AK respec-
tively. In order to minimize overestimation of interproton distances
due to potential artifactual e¡ects of spin di¡usion, all medium- and
long-range NOEs were classi¢ed as weak, with the corresponding
distance limit of 1.9^5 AK . Because of the signi¢cant contribution of
an excess of free peptide to the NOE spectra of 7PP in the presence of
arrestin, all strong sequential NOEs were given a distance limit of
1.9^3.5 AK instead of 1.9^2.7 AK , and no dihedral angles P and i
were restrained based on the sequential NOE intensities, essentially
as described before [12]. Earlier results for the C-terminal region of
transducin K subunit [9], which utilized similar procedures, were con-
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¢rmed in independent TrNOESY experiments utilizing tmix = 48 ms,
and structure calculations based on TrNOE and residual dipolar cou-
pling restraints [13]. Structure calculations involved distance geometry
(DISTGEOM of TINKER 3.9 [14]), 1000K restrained molecular dy-
namics and simulated annealing (ANNEAL, 15 ps total time) and
structure re¢nement (NEWTON, 0.001 RMS gradient). Calculations
utilized CHARMM force¢eld.
3. Results and discussion
The soluble polypeptide Rh(330^348) has been synthesized
chemically in fully phosphorylated form (seven-phospho-pep-
tide, 7PP [7]), and shown to duplicate major functions of the
native phosphorylated rhodopsin. 7PP inhibited phototrans-
duction from photoactivated unphosphorylated rhodopsin in
the presence of arrestin [15], and induced conformational
changes in arrestin typically observed upon interaction of ar-
restin with native phosphorylated rhodopsin [8]. These results
show that major structural features of the phosphorylated
C-terminal region of rhodopsin are preserved in 7PP, and
that it can be used to study structural dynamics of the rho-
dopsin^arrestin interface and the mechanism of the signal
shut-o¡.
Sections of 1H-TOCSY and 1H-NOESY spectra of 7PP
with or without bovine arrestin are overlaid in Fig. 1. The
continuous line in the NH-KH region (4.0^4.6 ppm) shows
sequential connectivity interrupted only at P347. Sequence-
speci¢c and stereospeci¢c assignment of NOE peaks was
done using standard procedures [9,12,16]. Proton resonance
assignments in ppm are given in Table 1.
Consistent with previous NMR studies [17,18], 7PP in so-
lution is highly disordered. The NOESY spectrum of 7PP
without arrestin shows no indications of structuring of this
peptide in solution. Many sequential NOEs in the NH-ali-
phatic region are very weak, suggesting high £exibility of
the side chains. No meaningful medium- or long-range
NOEs were identi¢ed for free 7PP in solution. This result is
also consistent with available X-ray structures of rhodopsin
[19], in which unphosphorylated Rh(330^348) is largely ex-
tended with a 328^333 region unresolved, and a site-directed
spin labeling study [20], which shows that the rhodopsin
C-terminal region is highly disordered and mobile.
After addition of arrestin, proton chemical shifts remained
essentially unchanged. Line width broadening in the presence
of arrestin was considerable, consistent with fast exchange
between free and bound forms. The exchange rate between
free and arrestin-bound forms of 7PP appears faster or similar
to the cross-relaxation rate in the bound state. N-terminal
amides of D330 and D331 are not observed due to the fast
exchange with solvent. LH protons of the phosphorylated
threonines overlap with the corresponding KH protons. Meth-
Fig. 1. Sections of 1H-TOCSY (blue) and 1H-NOESY spectra of 7PP in the absence (red) and in the presence (black) of bovine arrestin. The
amino acid sequence of 7PP is shown. Serine and threonine residues are phosphorylated.
FEBS 28196 15-4-04 Cyaan Magenta Geel Zwart
O.G. Kisselev et al./FEBS Letters 564 (2004) 307^311308
ylene protons exhibited signi¢cant chemical shift degeneracy
likely because of the equilibration between their nuclear spin
magnetizations, and despite acquisition of the NOESY spectra
at a 1H frequency of 600 MHz.
In contrast to the free form, in the presence of arrestin,
sequential NH-aliphatic interactions in 7PP are strong, espe-
cially in the C-terminal portion of the peptide, residues 339^
348. A total of 198 constraints were identi¢ed and used for
structure calculations of the arrestin-bound conformation
(Fig. 2a). In order to identify biologically relevant conforma-
tions of 7PP in the arrestin-bound state, the structure calcu-
lations based on the NMR-derived constraints were per-
formed on the full set of X-ray coordinates of rhodopsin
[19] with unresolved parts of loop C3 and the C-terminal
region rebuilt in Insight II. The starting conformation of a
rebuilt C-terminal region was mostly extended. Only region
Rh(324^348) was allowed to move during calculations. This
procedure has the bene¢t of visualizing arrestin-induced con-
formational changes in the context of the whole receptor and
provides a more focused conformational search. Fifteen low-
energy models out of 100 independently calculated NMR
structures were superimposed using main chain atoms. Coor-
dinates of the average structure and an ensemble of 15 struc-
tures of the Rh(330^348) region corresponding to 7PP were
deposited in PDB, under number 1NZS.
Table 1
Proton resonance assignments, in ppm
Atom 9 H Asp 330 N/A
Atom 10 HA Asp 330 N/A
Atom 11 1HB Asp 330 2.825
Atom 12 2HB Asp 330 2.730
Atom 22 H Asp 331 N/A
Atom 23 HA Asp 331 4.562
Atom 24 1HB Asp 331 2.622
Atom 25 2HB Asp 331 2.563
Atom 36 H Glu 332 8.480
Atom 37 HA Glu 332 4.240
Atom 38 1HB Glu 332 2.023
Atom 39 2HB Glu 332 1.898
Atom 40 1HG Glu 332 2.250
Atom 41 2HG Glu 332 2.250
Atom 48 H Ala 333 8.300
Atom 49 HA Ala 333 4.370
Atom 50 1HB Ala 333 1.396
Atom 51 2HB Ala 333 1.396
Atom 52 3HB Ala 333 1.396
Atom 59 H Ser 334 8.797
Atom 60 HA Ser 334 4.550
Atom 61 1HB Ser 334 4.080
Atom 62 2HB Ser 334 4.080
Atom 71 H Thr 335 8.591
Atom 72 HA Thr 335 4.445
Atom 73 HB Thr 335 4.430
Atom 74 1HG Thr 335 1.271
Atom 75 1HG2 Thr 335 1.271
Atom 85 H Thr 336 8.716
Atom 86 HA Thr 336 4.395
Atom 87 HB Thr 336 4.380
Atom 88 1HG Thr 336 1.263
Atom 89 1HG2 Thr 336 1.263
Atom 99 H Val 337 8.318
Atom 100 HA Val 337 4.199
Atom 101 HB Val 337 2.085
Atom 102 1HG1 Val 337 0.931
Atom 103 2HG1 Val 337 0.931
Atom 104 3HG1 Val 337 0.931
Atom 105 1HG2 Val 337 0.931
Atom 106 2HG2 Val 337 0.931
Atom 107 3HG2 Val 337 0.931
Atom 114 H Ser 338 8.791
Atom 115 HA Ser 338 4.490
Atom 116 1HB Ser 338 4.020
Atom 117 2HB Ser 338 4.020
Atom 128 H Lys 339 8.364
Atom 129 HA Lys 339 4.440
Atom 130 1HB Lys 339 1.819
Atom 131 2HB Lys 339 1.753
Atom 132 1HG Lys 339 1.415
Atom 133 2HG Lys 339 1.415
Atom 134 1HD Lys 339 1.652
Atom 135 2HD Lys 339 1.652
Atom 136 1HE Lys 339 2.930
Atom 137 2HE Lys 339 2.930
Atom 138 1HZ Lys 339 7.080
Atom 139 2HZ Lys 339 7.080
Atom 140 3HZ Lys 339 7.080
Atom 148 H Thr 340 8.851
Atom 149 HA Thr 340 4.261
Atom 150 HB Thr 340 4.260
Atom 151 1HG Thr 340 1.270
Atom 152 1HG2 Thr 340 1.270
Atom 164 H Glu 341 8.512
Atom 165 HA Glu 341 4.398
Atom 166 1HB Glu 341 2.050
Atom 167 2HB Glu 341 1.922
Atom 168 1HG Glu 341 2.271
Atom 169 2HG Glu 341 2.271
Atom 178 H Thr 342 8.708
Atom 179 HA Thr 342 4.530
Atom 180 HB Thr 342 4.529
Table 1 (Continued).
Atom 181 1HG Thr 342 1.261
Atom 182 1HG2 Thr 342 1.261
Atom 191 H Ser 343 8.910
Atom 192 HA Ser 343 4.463
Atom 193 1HB Ser 343 4.060
Atom 194 2HB Ser 343 4.060
Atom 205 H Gln 344 8.323
Atom 206 HA Gln 344 4.338
Atom 207 1HB Gln 344 2.082
Atom 208 2HB Gln 344 1.946
Atom 209 1HG Gln 344 2.341
Atom 210 2HG Gln 344 2.341
Atom 211 1HE2 Gln 344 7.780
Atom 212 2HE2 Gln 344 6.830
Atom 220 H Val 345 8.154
Atom 221 HA Val 345 4.037
Atom 222 HB Val 345 2.006
Atom 223 1HG1 Val 345 0.900
Atom 224 2HG1 Val 345 0.900
Atom 225 3HG1 Val 345 0.900
Atom 226 1HG2 Val 345 0.900
Atom 227 2HG2 Val 345 0.900
Atom 228 3HG2 Val 345 0.900
Atom 234 H Ala 346 8.453
Atom 235 HA Ala 346 4.570
Atom 236 1HB Ala 346 1.332
Atom 237 2HB Ala 346 1.332
Atom 238 3HB Ala 346 1.332
Atom 246 HA Pro 347 4.360
Atom 247 1HB Pro 347 1.936
Atom 248 2HB Pro 347 2.257
Atom 249 1HG Pro 347 1.997
Atom 250 2HG Pro 347 1.997
Atom 251 1HD Pro 347 3.700
Atom 252 2HD Pro 347 3.568
Atom 258 H Ala 348 7.972
Atom 259 HA Ala 348 4.074
Atom 260 1HB Ala 348 1.296
Atom 261 2HB Ala 348 1.296
Atom 262 3HB Ala 348 1.296
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Calculations based on the NMR-derived restraints show
that the N-terminus of the polypeptide remains £exible. How-
ever, the C-terminal region forms a stable helix-loop structure
in a manner that brings the N- and the C-termini of 7PP close
to each other (Fig. 2d). The overall hairpin fold of arrestin-
bound 7PP is supported by the long-range NOEs 348NH-
332QH, 344NH-331KH, and 347KH-333LH. Because of the
potential overlap of 348NH-332QH with 348NH-347QH, and
of 344NH-331KH with 346NH-331KH, these peaks cannot be
assigned unambiguously, and the corresponding distance re-
straints were excluded from the ¢nal distance matrix. The
C-terminal helix is consistent with a full set of sequential
NH^NH interactions, i,i+2 NOEs 343NH-341NH and
345NH-343NH, NOE peak of an NH-KH (i,i+4) type,
344NH-340KH, and strong 348^345 i,i+3 side chain interac-
tions. In addition, two H-bonds of an i,i+4 type were identi-
¢ed between main chain O and NH of 341^345 and 344^348
respectively during structure calculations, and corresponding
additional restraints of 1.9^2.1 AK were introduced during ¢nal
structure re¢nement. In the ¢nal ensemble of 15 NMR struc-
tures produced by independent calculations in the context of
the whole rhodopsin, the root mean square deviation, RMSD,
an indicator of how close the calculated structures are to each
other, shows poor convergence at the N-terminal region 330^
339 with RMSD for the main chain atoms of 1.78 U 0.34 AK
and 2.17 U 0.38 AK for the side chains. In contrast, the C-ter-
minal helical region 340^348 is highly compact with RMSDs
0.32U 0.14 AK and 0.67U 0.23 AK for the main and side chain
atoms respectively (Fig. 2b).
The results show that the seven-phospho-Rh(330^348) pep-
tide, 7PP, undergoes signi¢cant conformational changes upon
binding to arrestin. Because 7PP mimics major functions of
the native phosphorylated rhodopsin, such as induction of the
active conformation of arrestin, and inhibition of phototrans-
duction, conformational changes identi¢ed in this study are
likely to occur during rhodopsin^arrestin binding.
4. Coordinates
Atomic coordinates for the arrestin-bound C-terminal re-
gion of rhodopsin have been deposited in the Protein Data
Bank (accession code 1NZS).
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